M&A Deal Summary

Bayer Acquires AskBio

On October 26, 2020, Bayer acquired life science company AskBio for 2.0B USD

Acquisition Highlights
  • This is Bayer’s 7th transaction in the Life Science sector.
  • This is Bayer’s 3rd largest (disclosed) transaction.
  • This is Bayer’s 7th transaction in the United States.
  • This is Bayer’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2020-10-26
Target AskBio
Sector Life Science
Buyer(s) Bayer
Deal Type Add-on Acquisition
Deal Value 2.0B USD
Advisor(s) J.P. Morgan Securities (Financial)
Ropes & Gray (Legal)

Target

AskBio

Research Triangle Park, North Carolina, United States
Asklepios BioPharmaceutical, Inc. is a clinical-stage gene therapy platform company dedicated to improving the lives of children and adults with rare genetic disorders. AskBio’s gene therapy platform includes an industry-leading proprietary cell line manufacturing process known as Pro10TM and an extensive AAV capsid library. AskBio maintains a portfolio of clinical programs across a range of indications including Pompe, Limb-Girdle Muscular Dystrophy, Cystic Fibrosis, Myotonic Muscular Dystrophy, Hemophilia (Chatham Therapeutic/Takeda) and Duchenne Muscular Dystrophy (Bamboo Therapeutics/Pfizer). AskBio was established in 2001 and is based in Research Triangle Park, North Carolina.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bayer

Leverkusen, Germany
Category Company
Founded 1863
Sector Life Science
Employees98,189
Revenue 47.6B EUR (2023)
DESCRIPTION
Bayer office building in North Sydney, Australia.
Bayer office building in North Sydney, Australia.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.

DEAL STATS #
Overall 16 of 20
Sector (Life Science) 7 of 9
Type (Add-on Acquisition) 13 of 17
State (North Carolina) 1 of 1
Country (United States) 7 of 9
Year (2020) 2 of 2
Size (of disclosed) 3 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-01 Bayer AG - Profender and Drontal Products

Leverkusen, Germany

Bayer AG's Profender and Drontal Products are spot-on and tablet de-wormer products for cats and dogs.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-01 TruBiotics

Boca Raton, Florida, United States

TruBiotics contains a proprietary blend of two probiotic strains Bifidobacterium animalis BB-12 and Lactobacillus acidophilus LA-5 which is one of the most researched combinations of probiotic strains. Two types of beneficial bacteria found in the gut Bifidobacteria and Lactobacillus are important for both digestive and immune health support.

Sell -
Mergr

Product

Company

Legal